Tagged with Insight,

Pharma The head of KPMG’s life science division in Africa, Joubert Krugel, discusses the current state of South Africa’s healthcare system, the imminent trends taking place, and how the business community can improve the nature of collaboration with public stakeholders to increase widespread access to quality care in the country. How would…

Pharma Floris Van Haselen, Business Development Director Europe for O&M Movianto, one of the rare logistics companies to be fully specialized and to only operate in the healthcare sector, explains how the company wants to help its customers bring their products closer to the “Point of Care” thanks to its flexibility and expertise. With…

Pharma Christophe Lala, general manager of Western Europe at GE Healthcare, reveals how today the challenge is to ensure that all patients in France have access to the same medical pathway; how the future of medicine lies in early diagnosis and individually tailored treatments, what is known as personalized medicine; and…

Pharma Servier Egypt’s recently arrived general manager shares his first impressions and assessments of the Egyptian business environment, and discusses the potential he sees for Servier Egypt to build upon its already strong position in the market. After three months in Egypt, what is your initial assessment of the country? Upon…

Pharma Emmanuelle Ribot-Mariotte, general manager of Alfa Wassermann Pharma France, reveals how over the past year the company has been working hard on a new innovative treatment for hepatic encephalopathy, Rifaximin-alpha 500, and why their strategy is to focus on gastro-intestinal diseases, a field which has always been at the heart…

Pharma The MD of the Spanish Chamber of Commerce in Italy takes stock of the prevailing business winds between the two countries as both economies complete their emergence from the shadow of the global financial crisis. Citing the important contribution of entities such as Banca Farmafactoring in providing liquidity to pharmaceutical and…

Pharma Massimo Visentin, Country Leader for Pfizer Italy, discusses the company’s remarkable success in 2015, his hopes and ambitions for the new year, and the need of the industry and Pfizer specifically to engage the government in the development of a more sustainable healthcare system. To start off, we are approaching…

Pharma Phyto-Pharmaceuticals often offer better, more sustainable treatment solutions than synthetic pharmaceuticals, explains the Sekem group’s CEO Helmy Abouleish. Atos Pharma’s CEO Ashraf Mamdouh expands on the companies current plans for expansion in Egypt and internationally, as their manufacturing facility is currently awaiting EMA and FDA certification.  ATOS Pharma is a…

Pharmaceuticals Marius Fourie highlights implications of the recent merger between the company’s two subsidiaries and the unparalleled levels of value and service the consolidated organization will offer. He also illustrates the affiliate’s strategies in navigating the country’s dual-model healthcare system and the ways in which effective education and training can benefit all stakeholders…

Pharma Pharmaceuticals Isabelle de Walsche, Managing Director of Gedeon Richter Benelux, provides us with an update on the development of this striving and ambitious player in the women’s healthcare field and shares her multi-country experience in market access and innovation perception. The Gedeon Richter Benelux affiliate only opened in 2012. What were…

Pharma Automation and consolidation have affected pharmaceutical companies worldwide, and Puerto Rico is no exception. The island has benefited from the trend towards lower volume, higher value products which often use the smaller plants Puerto Rico offers. Some companies, like Merck, are transforming their sites from pure manufacturing to commercialization. These trends point to…

Pharma Puerto Rico is starting to move towards greater R&D activity. World class research centers in cardiovascular, oncology, and soon molecular science are putting the territory on the global map for pharmaceutical research. But Puerto Rico is starting to move beyond manufacturing and towards greater R&D activity. Puerto Rico’s Cardiovascular and…